Drug Firm Agrees to Pay One Billion Dollars in Major Scandal

Source: Mercola

A nearly decade-long civil investigation into the fraudulent marketing of Johnson & Johnson’s antipsychotic drug Risperdal may soon be coming to a close, with the drug giant agreeing to pay more than $1 billion to the United States and individual states to resolve the matter.

Negotiations over a criminal plea are still ongoing, and individual states may choose to pursue their own cases rather than join in to the federal government’s settlement.

This means J&J may be liable for far more money… considering the state of Texas alone is asking for more than $1 billion over Risperdal marketing.

Read More: Drug Firm Agrees to Pay One Billion Dollars in Major Scandal

This entry was posted in Headlines, Health Related and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply